| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |